Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3034 |
|
Actual shortage: | 241 (8%) | |
Anticipated shortage: | 18 (1%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2766 (91%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
30 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-ZOPICLONE | 7.5MG | TABLET | Resolved | 2023-03-30 | 2023-05-26 | 188421 |
APO-ALLOPURINOL | 200MG | TABLET | Resolved | 2023-03-30 | 2023-05-26 | 188424 |
APO-FLUVOXAMINE | 50MG | TABLET | Resolved | 2023-04-06 | 2023-07-27 | 188940 |
APO-PRAZO TAB 2MG | 2MG | TABLET | Actual shortage | 2023-04-06 | 2024-03-27 | 188943 |
APO-ZOPICLONE | 7.5MG | TABLET | Resolved | 2023-04-06 | 2023-05-26 | 188946 |
APO-TRYPTOPHAN | 500MG | TABLET | Resolved | 2023-04-06 | 2023-05-12 | 188949 |
APO-ATORVASTATIN | 80MG | TABLET | Resolved | 2023-04-06 | 2023-04-27 | 188976 |
TRI-CIRA 21 | 0.035MG 0.25MG 0.035MG 0.215MG 0.035MG 0.18MG | TABLET | Resolved | 2023-04-06 | 2023-08-12 | 188979 |
APO-LEVOCARB-TAB 25MG/100MG | 100MG 25MG | TABLET | Resolved | 2023-04-14 | 2023-05-06 | 189632 |
APO-SOTALOL | 80MG | TABLET | Resolved | 2023-04-14 | 2023-06-29 | 189635 |
APO-IBUPROFEN TAB 600MG | 600MG | TABLET | Resolved | 2023-04-14 | 2023-04-21 | 189638 |
APO-LEVETIRACETAM | 250MG | TABLET | Resolved | 2023-04-14 | 2023-06-23 | 189641 |
APO-MIRTAZAPINE | 30MG | TABLET | Resolved | 2023-04-14 | 2023-08-04 | 189644 |
APO-EMTRICITABINE-TENOFOVIR | 200MG 300MG | TABLET | Resolved | 2023-04-14 | 2023-05-19 | 189650 |
APO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR | 300MG 200MG 600MG | TABLET | Resolved | 2023-04-14 | 2023-07-07 | 189653 |
APO-CEPHALEX | 500MG | TABLET | Resolved | 2023-04-14 | 2023-10-20 | 189656 |
APO-MEDROXY TABLETS | 2.5MG | TABLET | Resolved | 2023-04-14 | 2024-03-22 | 189662 |
APO-MEDROXY TABLETS | 5MG | TABLET | Resolved | 2023-04-14 | 2024-03-22 | 189665 |
APO-MEDROXY | 100MG | TABLET | Resolved | 2023-04-14 | 2024-03-22 | 189671 |
APO-GLICLAZIDE | 80MG | TABLET | Resolved | 2023-04-21 | 2023-06-29 | 189988 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94446 | ||
APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94449 | ||
APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94452 | ||
APO-HYDROCHLOROTHIAZIDE | Discontinued | 2019-11-26 | 2019-11-26 | 99653 | ||
APO-IMIQUIMOD | Discontinued | 2019-11-26 | 2019-11-26 | 99672 | ||
APO-CARBAMAZEPINE | Discontinued | 2020-02-19 | 2020-02-19 | 106679 | ||
APO-NIZATIDINE | 150MG | CAPSULE | Discontinued | 2017-03-13 | 2017-03-13 | 1127 |
APO-NIZATIDINE | 300MG | CAPSULE | Discontinued | 2017-03-13 | 2017-03-13 | 1135 |
APO-NORTRIPTYLINE | 10MG | CAPSULE | Discontinued | 2017-03-13 | 2017-03-13 | 1145 |
APO-NORTRIPTYLINE | 25MG | CAPSULE | Discontinued | 2017-03-13 | 2017-03-13 | 1155 |
APO-GEMFIBROZIL CAP 300MG USP | 300MG | CAPSULE | Discontinued | 2017-03-31 | 2018-12-07 | 4920 |
APO-DOCUSATE SODIUM | 100MG | CAPSULE | Discontinued | 2018-02-23 | 2019-03-29 | 40733 |
DOCUSATE SODIUM CAPSULES | 100MG | CAPSULE | Discontinued | 2018-02-23 | 2018-09-15 | 40738 |
APO-AMOXI | 250MG | CAPSULE | Discontinued | 2018-09-07 | 2019-02-13 | 60171 |
APO-AMOXI | 500MG | CAPSULE | Discontinued | 2018-09-07 | 2018-11-09 | 60174 |
APO-ATOMOXETINE | 60MG | CAPSULE | Discontinued | 2018-09-07 | 2018-09-15 | 60273 |
APO-CELECOXIB | 100MG | CAPSULE | To be discontinued | 2018-09-07 | 2018-12-11 | 60363 |
APO-CELECOXIB | 200MG | CAPSULE | Discontinued | 2018-09-07 | 2021-01-21 | 60366 |
APO-CLINDAMYCIN | 150MG | CAPSULE | To be discontinued | 2018-09-07 | 2018-12-28 | 60396 |
APO-CLINDAMYCIN | 300MG | CAPSULE | Discontinued | 2018-09-07 | 2019-07-13 | 60399 |